Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Truist Securities Downgrades MEI Pharma to Hold

Truist Securities Downgrades MEI Pharma to Hold

Truist Securities analyst Robyn Karnauskas downgrades MEI Pharma (NASDAQ:MEIP) from Buy to Hold.

December 6, 2022

1 minute read

Truist Securities analyst Robyn Karnauskas downgrades MEI Pharma (NASDAQ:MEIP) from Buy to Hold.

Price Over Earnings Overview: Williams Companies

November 6, 3:45 PM

In the current session, the stock is trading at $36.24, after a 0.44% increase. Over the past month,…

May 28, 8:01 AM

Analysts’ ratings for Autoliv (NYSE:ALV) over the last quarter vary from bullish to bearish, as provided by 8…

August 19, 10:00 AM

As Elon Musk and Twitter Inc. (NYSE: TWTR) prepare for a legal showdown on Oct. 17, the Tesla Inc.

May 7, 1:47 PM

U.S. immigration rebound stabilizes wages and inflation. The large influx of low-wage labor helped fill shortages.